NCT06475157View on ClinicalTrials.gov

Artificial Intelligence-enhanced Electrocardiogram Diagnoses and Predicts Future Regurgitant Valvular Heart Diseases

CompletedOBSERVATIONAL
Enrollment

500,000

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
Electrocardiogram, Valvular Heart Disease
Interventions
OTHER

No intervention

No intervention is applied.

Trial Locations (2)

200032

180 Fenglin Road, Shanghai

Unknown

Hammersmiths Hospital, London

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT06475157 - Artificial Intelligence-enhanced Electrocardiogram Diagnoses and Predicts Future Regurgitant Valvular Heart Diseases | Biotech Hunter | Biotech Hunter